Challenges in Breast Cancer Management: Recurrent Disease, Reconstruction and Hypofractionation

This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer. The second discussant assesses the challenges of reconstructive surgery in patients with recurrent breast cancer. The third discussant assesses the role of post-mastectomy hypofractionation in practice, with an analysis of the RT CHARM and FABREC trials. 

Topics:

  1. Double Exposure: Clinical and Scientific Perspectives on Breast Reirradiation
    Jose G. Bazan, Jr., MD, MS
  2. Reconstructive Surgery and Recurrent Breast Cancer 
    David S. Chang, MD
  3. Hypofractionation in Post-mastectomy Patients
    Rinaa S. Punglia, MD, FASTRO, MPH
  4. Q and A
    Christine S. Chung, MD, MPH, FASTRO - Moderator
    Full Panel

This activity is available from March 3, 2026, through 11:59 p.m. Eastern time on March 2, 2028. 

The content was originally presented and recorded at the 2025 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of radiation oncologists, physicists, nurses, radiation therapists, radiation dosimetrists, plastic surgeons and residents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss radiation and reconstructive surgery treatment options for patients with recurrent breast cancer.  
  • Discuss indications for hypofractionated radiation in post-mastectomy patients.  
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
03/03/2026
Course expires: 
03/02/2028
Cost:
$149.00
Rating: 
0

Moderator: 

  • Christine S. Chung, MD, FASTRO, MPH, is employed by John Muir Medical Center and the University of California San Francisco. Dr. Chung has no relevant financial relationship with ineligible companies to disclose. 

Speakers: 

  • Jose G. Bazan, Jr., MD, MS, is employed by City of Hope National Medical Center. Dr. Bazan has no relevant financial relationship with ineligible companies to disclose.  
  • David S. Chang, MD, is employed by Kind/Chang Plastic Surgery. Dr. Chang has no relevant financial relationship with ineligible companies to disclose. 
  • Rinaa S. Punglia, MD, FASTRO, MPH, is employed by Dana-Farber Cancer Institute/Brigham and Women's Cancer Center.  

Planners: 

  • Malcolm Mattes, MD is employed at Rutgers Cancer Institute. Dr. Mattes received research/grant funding from Gilead Sciences (relationship ended 8/30/2025). Dr. Mattes has no relevant financial relationship with ineligible companies. 
  • Parul Barry, MD, is employed by the University of Pittsburgh Medical Center. Dr. Barry has no relevant financial relationship with ineligible companies. 
  • Michael Haddock, MD, is employed by Mayo Clinic and has no relevant financial relationship with ineligible companies to disclose.
  • Manisha Palta, MD, is employed by Duke Cancer Center and Duke University Hospital. Dr. Palta receives grant/research funding from Merck and Varian Medical Systems. 
  • Salma Jabbour, MD, is employed by Rutgers Cancer Institute. Dr. Jabbour receives grant/research funding from Merck & Co., Inc. and Beigene. Dr. Jabbour receives compensation/payment as a consultant with Radialogica and IMX Medical.

All relevant financial relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $149
  • Member: $99
  • Member-in-Training: $49
  • Student/Graduate Student/PGY-1 Member: $49
  • Postdoctoral Fellow Member: $49

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until March 2, 2028, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.